Blood Vessels News and Research

RSS

Exercise helps overweight men with erectile dysfunction

Erectile dysfunction is known to decrease the quality of life in men, and may affect as many as 30 million men in the United States alone, according to the new study. In a previous study, moderate-to-severe erectile dysfunction was reported by 12 percent of men below the age of 59; 22 percent of men aged 60 to 69 years; and 30 percent of 69 years and older.

22 Jun 2004

We want to figure out how to grow new kidneys in humans

Growing new organs to take the place of damaged or diseased ones is moving from science fiction to reality, according to researchers at Washington University School of Medicine in St. Louis.

22 Jun 2004

New computer cluster will help understanding of how human cells and organs work

A new computer cluster funded by the University of Sheffield and located within the Royal Hallamshire Hospital, will help scientists to improve their understanding of how human cells and organs work.

22 Jun 2004

Erectile dysfunction and type 2 diabetes could mean heart disease

Men who had silent, or symptomless, coronary artery disease (CAD) and type 2 diabetes were nine times as likely to have erectile dysfunction (ED) as were diabetic men who did not have silent heart disease.

22 Jun 2004

Minimally invasive procedure provides new childbirth hope

Beauty therapist, Jo Anastasio, who suffers from an extremely rare blood vessel abnormality, was told that she couldn’t have children and that her only option was a hysterectomy.

21 Jun 2004

Cooling method to treat brain aneurysms

Patients who undergo brain surgery to treat aneurysms are at risk for permanent brain damage, but a protective cooling system is now being tested at Rush University Medical Center to reduce or eliminate this risk.

21 Jun 2004

Aggressive treatment of brain blood clots can produce a good outcome for many stroke patients

In the study, published in a recent issue of the journal Neurosurgery, 50 percent of stroke patients had little or no neurological disability one to three months after clot-dissolving medication was delivered directly to the site of the blockages, compared to 39 percent of patients with similarly good outcomes documented in a large national trial of intravenous (IV) drug treatment for stroke.

21 Jun 2004

Computer cluster helps understand how human cells and organs work

This will ultimately lead to more effective ways of treating cardiovascular disease and cancer as well as other diseases. It will also eventually allow doctors to tailor treatment in a way specific to that patient rather than a ‘one-size-fits-all’ approach.

17 Jun 2004

Potential new strategy for blocking tumor growth

Targeting a master molecule that helps cancer cells survive when blood oxygen levels are low may offer a potentially powerful strategy for blocking tumor growth, say researchers at The University of Texas M. D. Anderson Cancer Center.

16 Jun 2004

Magnetic resonance spectroscopy identifies women with chest pain at high risk

Women with chest pain who have a normal coronary angiogram can benefit from a test that detects abnormal metabolism in their heart muscle, according to a study reported in today’s rapid access issue of Circulation: Journal of the American Heart Association.

16 Jun 2004

New material, cellular perfluoroelastomers could revolutionise surgery and save lives

The proprietary material was originally developed by the Manchester based company to make artificial blood vessels, used to replace diseased arteries which can lead to heart attacks and strokes, and is capable of making significant improvements in surgery for vascular disease.

16 Jun 2004

65 percent of America’s adults are overweight and 31 percent of adults are obese and at risk for chronic diseases

Government and private sector health experts now estimate that 65 percent of America’s adults are overweight and 31 percent of adults are obese and at risk for chronic diseases such as diabetes and hypertension. The link between obesity and hypertension is well known, but the exact nature of the association between the two disorders remains unclear.

11 Jun 2004

African Americans suffer from cardiovascular diseases at a rate about five times higher than the rest of the U.S. population

African Americans suffer from cardiovascular diseases at a rate about five times higher than the rest of the U.S. population. In a new study, scientists may have found a culprit: a serious deficiency of nitric oxide, a small molecule vital in the regulation of blood flow and blood pressure.

11 Jun 2004

Foundation for poor heart health laid early in life

Heart disease - long viewed as a scourge of adulthood - is a growing threat to children because of soaring rates of obesity and related problems, such as diabetes.

9 Jun 2004

SU11248 proves effective in the treatment of gastrointestinal stromal tumors

A drug originally developed to block the formation of blood vessels in tumors has been shown to overcome resistance to treatment with Gleevec in patients with gastrointestinal stromal tumors (GIST).

9 Jun 2004

Breakthrough in gene therapy

Despite a roller-coaster ride of ups and downs during the past 15 years, gene therapy has continued to attract many of the world's brightest scientists. They are tantalized by the enormous potential that replacing missing genes or disabling defective ones offers for curing diseases of many kinds.

3 Jun 2004

Drug helps patients with metastatic colorectal cancer

A drug designed to cut off a tumor’s blood supply, when paired with a chemotherapy combination, resulted in significant improvement in survival in patients with metastatic colorectal cancer, the first time in decades that survival times have been extended in patients with this devastating form of advanced cancer.

3 Jun 2004

Drug to extend lives of colorectal cancer patients

A drug designed to cut off a tumor's blood supply, when paired with a chemotherapy combination, resulted in significant improvement in survival in patients with metastatic colorectal cancer, the first time in decades that survival times have been extended in patients with this devastating form of advanced cancer.

2 Jun 2004

Avastin study shows significant improvement in patients with metastatic colorectal cancer

Genentech, Inc. and Roche have announced that the New England Journal of Medicine published the first Phase III study of an anti-angiogenesis cancer therapy, showing that the addition of Avastin™ (bevacizumab) to the IFL chemotherapy regimen (5-FU/Leucovorin/ CPT-11) significantly extended survival in patients with first-line (previously untreated) metastatic colorectal cancer.

2 Jun 2004

Innovative type of brain scan can determine where blockages of blood to the brain lie

It's a no-brainer that the brain needs a constant supply of blood to keep it going. But some medical conditions can block or reduce that life-giving flow. Whether it's a stroke, a clogged artery or a brain tumor, any situation where blood can't get to the whole brain can lead to death or permanent disability.

2 Jun 2004